Melatonin associated with acid inhibition as a strategy for chemoprevention in Barrett's esophagus. pilot study [Melatonina asociada a inhibicion acida como estrategia de quimioprevencion en esofago de Barrett. Estudio piloto].
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Melatonin (Primary) ; Omeprazole
- Indications Barrett's oesophagus; Oesophageal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 20 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials.
- 20 Apr 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; 95230916).